Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

SELL
$203.72 - $248.97 $78,839 - $96,351
-387 Reduced 9.35%
3,754 $0
Q3 2022

Nov 01, 2022

SELL
$204.81 - $262.19 $50,383 - $64,498
-246 Reduced 5.61%
4,141 $848,000
Q2 2022

Jul 25, 2022

BUY
$213.86 - $277.87 $938,203 - $1.22 Million
4,387 New
4,387 $1.03 Million
Q1 2021

Apr 20, 2021

SELL
$204.88 - $255.03 $4,097 - $5,100
-20 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$186.91 - $214.42 $3,738 - $4,288
20 New
20 $4,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.